Personalized medicine uses methods of molecular analysis, especially genetic sequencing and transcription, in order to simultaneously identify genetic mutations to evaluate each individual’s risk of contracting a given disease. It seems that there is more than a single mechanism at hand, as proven by the work of a team of geneticists at the University of Geneva’s (UNIGE) Faculty of Medicine, and the SIB Swiss Institute of Bioinformatics.
They concluded that establishing the list of mutations present in a person’s genome is not sufficient to predict that person’s future health. The study can be found in the latest online edition of Nature Genetics.
Full Media Release: English - French